AND
Organize the
Translational Research Driving Clinical Advances
Cancer continues to represent a major global health challenge, characterized by complex molecular heterogeneity, dynamic tumor microenvironments, and variable patient responses to therapy. Despite significant progress in understanding oncogenic pathways, epigenetic regulation, and tumor immunology, the translation of fundamental research into clinical interventions remains limited.
The Moroccan Cancer Research Society 2026 (MCRS-2026) provides a dedicated platform for integrating basic, translational, and clinical oncology research, fostering interdisciplinary collaboration among molecular biologists, oncologists, bioinformaticians, and healthcare innovators.
Disseminating cutting-edge discoveries in cancer genomics, proteomics, metabolomics, and immuno-oncology.
Promoting translational research that bridges molecular insights with novel therapeutic strategies, including targeted therapies, immunotherapies, and precision medicine approaches.
Examining advances in clinical oncology, including adaptive trial designs, biomarker-driven therapies, and integrative patient management.
Highlight technological innovations: AI, digital pathology, and predictive modelling, such as artificial intelligence, machine learning, and digital pathology, to enhance diagnostics, treatment planning, and patient monitoring.
Facilitating multidisciplinary exchange through workshops, interactive sessions, and collaborative research networks to accelerate the implementation of evidence-based interventions.
By convening global experts, MCRS-2026 aims to catalyze the translation of scientific knowledge into effective clinical practice, ultimately improving patient outcomes and advancing the global oncology research agenda. This congress underscores the critical interplay between mechanistic research and clinical application, providing a rigorous scientific forum for the next generation of cancer breakthroughs.
Reserved for high-impact studies submitted shortly before the congress, this session highlights the most recent advances in cancer research. Presentations focused on either clinical, epidemiological, fundamental and translational research are 30 minutes each, including Q&A.
Held daily during the congress, poster sessions allow researchers to present their work in an interactive, visual format. Presenters will be available at their posters during scheduled hours to answer questions, discuss findings, and engage with attendees. Selected posters may be considered for awards.
In these fast-paced session, early-career researchers deliver brief 5–8-minute presentations summarizing their findings, followed by a 2–3-minute audience Q&A. This format highlights emerging science and provides a snapshot of diverse topics in cancer research. PhDs and Master students are encouraged to share their research topics.
A platform for clinicians, fellows, and trainees to present unique or complex cases (five or fewer patients) highlighting unusual presentations, rare complications, or innovative approaches. This section also includes Psychology and Nutrition, addressing mental health and dietary challenges in cancer care, and discusses difficulties different countries face in validating treatments internationally, with insights from surgeons on managing such challenges.